New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
Cervarix, a cervical cancer vaccine produced by Glaxo
Smithkline (Britain's biggest drug manufacturer) is being registered for approval// by the European regulatory authority. If approved, the vaccine would be marketed for commercial use, by the end of next year.
Gardasil, a similar vaccine ...
PDL BioPharma Elects Barry Selick to Its Board of Directors
...chnology company Camitro Corporation. From 1992 to 1999, he worked at Affymax Research Institute, the drug discovery technology development center for glaxo
Wellcome plc, most recently as vice president of Research. Prior to joining Affymax, he held scientific positions at Protein Design Labs, Inc. and Ane...
Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning
...ffairs and hundreds of U.S. hospitals, including Mayo, Columbia Presbyterian, the Cleveland Clinic and Bethesda Naval Hospital. Pharmas such as Roche, glaxo
Smithkline and Ortho Biotech have distributed over half a million CDs to Chemotherapy and Radiation patients around the English speaking world, and th...
Prasco Selected as GSK's Generics Marketing and Distribution Agent
...perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older.
FLONASE(R) is a registered trademark of glaxo
Group Limited, UK.
Prasco's mission is to provide both quality products and significant cost-savings to the consumer. Prasco's...
MaxCyte Presents a Panel Discussion With Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery - LIVE Q&A to Follow
One of the respected industry experts who led the discussion was Dr. John Reardon, formerly Senior Vice President of Discovery Research Biology at glaxo
Smith Kline and now Executive Vice President and Chief Scientific Officer at Integrated Oncology Solutions Inc. (IOS) in North Carolina. Dr. Reardon r...
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
...t, Inc. Previously, he served in various positions at
Schering-Plough Corporation/Key Pharmaceuticals, Lowe McAdams Healthcare
advertising agency, and glaxo
Wellcome, where he was honored as a top sales
representative. Garbarini holds a B.S. degree in economics from the College
of New Jersey and an M.B.A. ...
New Genetic Links to Baldness Discovered
...ne to prevent hair loss in people with the gene variants is another story, Brockschmidt acknowledged. One of the new studies was financed, in part, by glaxo
SmithKline, a pharmaceutical company that might seek commercial benefit from its support. And one small company already markets a $149 genetic screeni...
Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives
...ginal introduction of the detail bag we have received valuable feedback from pharmaceutical representatives and companies such as Eli Lilly, Astellas, glaxo
Smith Kline, Wyeth, Teva Spatiality, TPNA, Johnson and Johnson, Medicis, Roche, Proctor and Gamble, Sanoff-Aventis, Novartis, AstraZeneca and Skinceu...
Senetek PLC Announces Key Personnel Appointments
...ational pharmaceutical research, development and sales and marketing
organizations. For nine years, Mr. Rose was Vice President of Corporate
Sales for glaxo
Pharmaceuticals, Inc. In 1997 he became Vice President and
General Manager of North American Operations for ICN Pharmaceuticals, Inc.
(now Valeant Pha...
Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
... 2000, Dr. Knight served as Director of Molecular
Biochemistry in the Biochemistry Division of Glaxo-Wellcome. He also held
several positions with the glaxo
Research Institute/Glaxo, Inc. from
1992-1995, later becoming head of the Dept. of Biochemistry and Protein
Engineering in the Division of Molecular S...
Glaxo in Biological News
Tamoxifen-like drug suggests new ways to selectively block estrogen
...40 to 50 in progress."
GW5638 was developed as a variation on tamoxifen in the early 1990s by co-author Tim Willson and colleagues at what was then glaxo
Wellcome, hence the name GW5638. McDonnell, at Duke, recognized its potential and demonstrated efficacy in animal models of tamoxifen-resistant breast...
Glaxo in Biological Technology
Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
...was later appointed Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals. Following the merger of SmithKline Beecham with glaxo
Wellcome in 2000, he returned to the United States as Senior Vice President for Worldwide Business Development.
Dr. Greig also serves on the boar...
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
...layers operating in the marketplace include Amgen Inc, Novartis, AstraZeneca plc, Genentech, Roche, OSI Pharmaceuticals, Pfizer, Bristol-Myers Squibb, glaxo
SmithKline, Wyeth, Onyx Pharmaceuticals Inc., Merck & Co. Inc, KAI Pharmaceuticals Inc, Celgene Corporation, Sanofi-Aventis, and Bayer Schering Ph...
Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents
... Over that time he served as Vice President in the Corporate Division; Vice President of National Accounts; Vice President and General Manager of the glaxo
Dermatology group; and Director of Managed Health Care.
From 1981 to 1986, Mr. McGarity worked as Vice President of Sales and Marketing at Westwo...
Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia
...iologics, and China is a critical component of our strategy at aTyr," said Dr. Schimmel. "Similar to our efforts at Sirtris Pharma, which was sold to glaxo
Smith Kline for $720M in 2008, we will leverage operations in Hong Kong to effectively and efficiently discover and characterize new compositions. Ba...
Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders
Mr. Thomas Williams, BSc (Hons)
Tom Williams, BSc (Hons), has had extensive experience in pharmaceutical and biotech companies beginning with glaxo
Australia where he was responsible for new drug applications and introducing new mediabased marketing methods. He recently retired as CEO of listed bi...
GeneNews announces management changes
... National Sales Manager and, prior to that, Government Relations and Reimbursement Manager. Prior to his tenure at Medtronic, he spent nine years with glaxo
Canada (now GSK) with responsibility for a number of pharmaceutical products.
Mr.Young is the former Director of Corporate Compliance for OccuLogix....
Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences
...erienced biotechnology and
pharmaceutical executive, currently serving as Lead Director of Genentech.
He has also served as chief executive officer of glaxo
Inc., from 1989-1994
and chairman of the board from 1992-1995. In addition, Dr. Sanders is also
a member of the Boards of Directors of Vertex Pharmace...
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
percent to euro 2.5 billion in 2007.
Global pharmaceutical companies such as AstraZeneca, Bristol Meyers
Squibb, Daiichi Sankyo, Eli Lilly, glaxo
Smith Kline, Johnson & Johnson,
Merck, Novartis, and Pfizer have selected Menarini to sell some of their
most important brands in Europe, including at...
Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
...ployee that Mr. Campbell hired upon founding the firm.
"My relationship with Nader dates back more than 14 years to when we
first worked together at glaxo
[now GlaxoSmithKline]. I have depended on
him as my friend and trusted business advisor since that time. I'm proud to
appoint him to this new senior e...
Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
...xecutive management team, on a part-time basis during this year,
to provide scientific leadership and guidance. He has held global
leadership roles at glaxo
Wellcome and Burroughs Wellcome and in recent
years, at Valeant Pharmaceuticals International and Anadys Pharmaceuticals,
Inc, a company he co-founded...